PATENT CLAIM ANALYSIS

Application Number: 15769295
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "243000"]

Abstract:
The present invention provides a compound which has a cholinergic muscarinic M1 receptor positive allosteric modulator activity and may be useful as a medicament such as an agent for the prophylaxis or treatment of Alzheimer's disease, schizophrenia, pain, sleep disorder, Parkinson's disease dementia, Lewy body dementia and the like. The present invention relates to a compound represented by the formula (I) or a salt thereof. In the formula (I), each symbol is as described in the attached specification.

Claim (Index 3):
The compound according to  claim 1 , wherein\n R 1  is a hydrogen atom, a halogen atom, a C 1-6  alkyl group or a C 1-6  alkoxy group; R 2  is a hydrogen atom, a halogen atom, a C 1-6  alkyl group or a C 1-6  alkoxy group; R 3  is (1) a hydrogen atom, (2) a C 1-6  alkyl group optionally substituted by 1 to 3 substituents selected from 3- to 14-membered non-aromatic heterocyclic groups, (3) a 3- to 14-membered non-aromatic heterocyclic group optionally substituted by 1 to 3 hydroxy groups, (4) a 5- to 14-membered aromatic heterocyclic group optionally substituted 1 to 3 cyano groups, (5) a C 3-10  cycloalkyl group optionally substituted by 1 to 3 hydroxy groups, or (6) a C 6-14  aryl group optionally substituted by 1 to 3 substituents selected from (a) a halogen atom, and (b) a cyano group; ring A is (1) a benzene ring optionally further substituted by 1 to 3 substituents selected from (a) a halogen atom, (b) a cyano group, (c) a C 1-6  alkoxy group optionally substituted by 1 to 5 halogen atoms, and (d) a 5- to 14-membered aromatic heterocyclic group optionally substituted by 1 to 3 C 1-6  alkyl groups, (2) a 5- or 6-membered monocyclic aromatic heterocycle optionally further substituted by 1 to 3 substituents selected from (a) a halogen atom, (b) a C 1-6  alkyl group, and (c) a 5- to 14-membered aromatic heterocyclic group optionally substituted by 1 to 3 C 1-6  alkyl groups, or (3) a 4- to 6-membered monocyclic non-aromatic heterocycle optionally further substituted by 1 to 3 substituents selected from (a) a cyano group, and (b) a 5- to 14-membered aromatic heterocyclic group; and X is CH or N, or a salt thereof.

Metadata:
- Claim Count in Document: 12.0
- Percentile: 91.0
- Lexical Diversity: 1.47619
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15735418', '15830634', '16083295', '15306012', '15318552']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8113899710659493
- 35 USC 102 Novelty (BERT): 0.5800430588256118
- Combined Prediction Score: 0.7882552798419157
- Mean Citation Score: 438.68419000000006
- Max Citation Score: 456.96445
- Similarity Product: 434.2923105745912

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test